Developments in multiple myeloma - immunotherapy and personalized medicine
Graft-versus-host disease (GvHD): Advances at EBMT 2016
What are the challenges of allogeneic stem cell transplant in myeloma?
Side effects of novel drugs and managing patient expectations in CLL
Idelalisib plus bendamustine and rituximab improves the outcome of relapsed/refractory CLL